About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Voice Feminisation in Transgender Women | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03899896

Voice Feminisation in Transgender Women

The voice is a reflection of our identity. In the case of transgender women, there may be a gap between perceived male voice and female appearance. Indeed, hormonal treatment in transgender women has ...

Lead sponsor: Central Hospital, Nancy, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Central Hospital, Nancy, France

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Age ≥ 18 years
•Follow-up in the Department of Endocrinology, Diabetology and Nutrition of the University Hospital of Nancy
•Gender dysphoria according to the ICD 11
•Voluntary, informed consent to participate in research
•Compulsory affiliation to the social security system

Exclusion Criteria

•Refusal or incapacity to be involved in the study

Related studies

The Effect of Gender-affirmative Measures on Breast Perception in Trans Men

NCT07252687 · Transgender, Gender Dysphoria in Adolescents and Adults

Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

NCT07147166 · Gender Dysphoria, Mastectomy, and more

RECRUITINGPhase 2

Progesterone in Gender Affirming Hormone Therapy Study

NCT06807580 · Transgender Women

RECRUITINGPhase 3

Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries

NCT04979338 · Gender Dysphoria

RECRUITINGPhase 3

Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

NCT06969326 · Postoperative Bleeding, Gender Dysphoria, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 25, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment77

Start dateFeb 2019

Last updatedJul 25, 2022

Condition

Speech Therapy Transgender Women Gender Dysphoria

Locations shown

University Hospital Nancy

Vandœuvre-lès-Nancy

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 25, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions